Additional file 1.

Figure S1. Chemical structures of the 11 other high-scoring compounds selected for preliminary biological evaluation. Figure S2. Preliminary experimental screening of the 12 compounds on inhibition of cellular IKKβ mediated NF-κB activity. Table S1. Chemical name and structures of benzoic acid derivatives reported to target the NF-κB signaling pathway. Table S2. Lowest-energy binding pose of the 11 other compounds with the ATP binding site in the KD domain of IKKβ. Table S3. Binding poses and ICM docking energies of compound 1 to other four kinases. The reference compounds are displayed in cyan.

Format: DOCX Size: 6.9MB Download file

Leung et al. BMC Pharmacology and Toxicology 2013 14:3   doi:10.1186/2050-6511-14-3